Not Just A Roll-Up, But A Coverup: Is AHCO The Next MDCA?
Jehoshaphat Research is short Adapthealth Corp (NASDAQ:AHCO). Q2 2021 hedge fund letters, conferences and more We believe that AdaptHealth (NASDAQ:AHCO), a roll-up of roll-ups with excessive debt, is deceiving the investor community via its financial reporting practices. While management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing double-digit organic decline. It is also, in our opinion, taking steps to obscure that decline which are expressly forbidden by the SEC.i This may explain the recent departures of the CFO, CSO, CTO and ...